Use of DCD organs: Expanding the donor pool to increase pediatric transplantation

Christine S Hwang1,2, Malcolm MacConmara1,2, André A S Dick3,4

  • 1Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Pediatric Transplantation
|January 31, 2022
PubMed

Insights

Organ donation after circulatory death (DCD) offers a solution to pediatric organ scarcity. Carefully selected DCD organs show promising outcomes in pediatric liver and kidney transplants, similar to donation after brain death (DBD) donors.

Area of Science:

  • Pediatric Transplantation
  • Organ Donation and Transplantation
  • Nephrology and Hepatology

Background:

  • A persistent gap exists between the number of children awaiting transplants and the availability of donor organs.
  • Transplant rates for pediatric liver and kidney recipients have remained stagnant over the last decade.
  • Donation after circulatory death (DCD) presents a potential strategy to address organ scarcity in transplantation.

Purpose of the Study:

  • To review the current literature on the utilization of DCD donor organs in pediatric liver and kidney transplantation.
  • To evaluate the outcomes of pediatric transplants utilizing DCD-derived allografts.
  • To assess the viability of DCD organs as a method to increase organ availability for pediatric recipients.

Main Methods:

  • Systematic literature review of studies reporting on pediatric liver and kidney transplantation using DCD donors.
  • Analysis of organ utilization rates and patient/allograft survival data.
  • Comparison of outcomes between DCD and donation after brain death (DBD) donor organs in pediatric recipients.

Main Results:

  • The utilization of DCD organs in pediatric transplantation is currently limited but shows potential for growth.
  • Pediatric transplants performed with carefully selected DCD liver and kidney allografts demonstrate outcomes comparable to those from DBD donors.
  • Evidence suggests that DCD organs can achieve similar success rates to DBD organs in pediatric recipients.

Conclusions:

  • DCD donation represents a viable strategy to mitigate organ scarcity in pediatric transplantation.
  • Careful selection and utilization of DCD organs can lead to successful pediatric liver and kidney transplant outcomes.
  • Increased use of DCD organs could significantly improve organ availability for children in need of transplantation.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
69
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
538
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
551